Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Zhuhai Yuanzhi Health Technology Co., Ltd., established on 2019-01-31, The business scope includes the business scope recorded in the articles of association:medicine,food,cosmetic,Biological product,Research and Development of Medical Devices,production and sales;technical consulting,Technical Training,technology transfer,Technical Services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Wellcome Gene Technology Co., Ltd., established on 2017-12-05, Business scope includes licensed projects:Inspection and testing service;Experimental animal management;pharmaceutical production;Drug retail;feed production;Feed additive production;Veterinary drug production;Veterinary drug business;Animal Clinic;Import and export;Technology Import and Export;Import and export agency;Drug import and export;Food import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of experimental analysis instruments;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Bio-feed R&D;Feed Additive Sales;pet service(No Animal Treatment);Manufacturing of daily chemical products;Sales of daily chemical products;software development;Artificial intelligence basic software development;Artificial intelligence theory and algorithm software development;Artificial intelligence application software development;Artificial intelligence public service platform technical consulting services;Network and Information Security Software Development;Information Technology Consulting Services;internet data service;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Sales of office equipment consumables;Conference and Exhibition Services;Educational Consulting Services(Education and training activities that do not include licensing approval)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Shenzhen Hanhui Pharmaceutical Technology Co., Ltd., established on 2021-12-28, Business scope includes general business items:Health Consulting Services(Does not include medical services);R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;Medical Research and Experimental Development;Domestic trade agent;trade agent;Retailing of protective equipment for healthcare workers;Retailing of Class II Medical Devices;Information Technology Consulting Services;Information Consulting Service(Not including licensing information consulting services);Consulting and planning service;marketing planning;Natural science research and experimental development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Drug import and export;Drug Wholesale;Drug retail;Drug internet information service;Quality inspection technical service;Technology Import and Export;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Import and export;Duty-free merchandise sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

Wuhan Celia Biotechnology Co., Ltd., established on 2020-05-07, Business scope includes molecular biology products,Cell Culture Products,Immunology Products,R&D and technical consultation of antigen and antibody products,technology transfer;Testing and Inspection Services;laboratory instrument,Consumables,Office Equipment and Supplies,Wholesale and retail of home appliances.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs. The company’s product portfolio includes Satraplatin, a platinum-based small molecule for prostate cancer; MAb 1D09C3, a monoclonal antibody for lymphoma; and RGB-286199, a small molecule for refractory cancer. In March 2000, the company acquired Mitotix, Inc., an American drug discovery and development company focused on treatments for cancer and fungal infections. GPC Biotech was founded in 1997 and currently operates as a subsidiary of Agennix AG.

Henan Beiwei Technology Co., Ltd., established on 2014-08-05, Business scope includes research and development of medical devices,Production,Sales;Research and Development of Scientific Instruments,Production,Sales,Maintenance and technology transfer,Technical Advisory Services;Accessories and consumables sales;Technology development of computer hardware and software,technical consulting,Technical service and sales;Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals);Equipment rental service;Import and export of goods or technology(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department).

Guangzhou Huazhen Pharmaceutical Technology Co., Ltd., established on 2016-12-01, Business scope includes scientific and technological information consulting services;Natural science research and experimental development;Biomedical Technology Research;drug development;Health Sciences Program Research,to develop;

Shanghai Meizhan Biotechnology Co., Ltd., established on 2017-12-28, The scope of business includes engaging in biotechnology,Medical Technology,Chemical Technology,Technology development in the field of medical technology,Technical Services,technical consulting,technology transfer,Business Consulting,Health Management Consulting,Engaged in the import and export of goods and technology,Market information consultation and investigation(Do not engage in social investigation,social research,poll,opinion poll),Class I medical device,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Electromechanical equipment and accessories,pipeline,valve,electronic product,computer,Software and Auxiliary Equipment,Wujinjiaodian,Office Supplies,Wholesale of craft gifts,retail,laboratory equipment,Instrumentation installation,repair,wholesale,retail,account Serive,Sales of edible agricultural products. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Sanyo Chemical Industries, Ltd. engages in the manufacture and sale of chemicals. It operates through the following segments: Toiletries and Health Care; Petroleum and Automotives; Plastics and Textiles; Information and Electronics; and Environmental Protection, Construction, and Others. The Toiletries and Health Care segment manufactures and supplies surfactants for detergents, cleaning agents, and toiletries; pharmaceutical additives; and superabsorbent polymers. The Petroleum and Automotives segment develops and distributes thermoplastic polyurethane beads (TUB) for the interior parts of automobiles, raw materials for polyurethane foams, and lubricating oil additives. The Plastics and Textiles segment offers permanent antistatic agents, and carbon fiber and fiberglass agents. The Information and Electronics segment includes polymerization toners, toner binders, and electrolytes for aluminum electrolytic capacitors. The Environmental Protection, Construction, and Others segment manufactures and distributes polymer flocculants for wastewater treatment, and polyurethane insulation raw materials. The company was founded on November 1, 1949 and is headquartered in Kyoto, Japan.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Chongqing Xier'an Pharmaceutical Co., Ltd., established on 1994-03-01, Business scope includes licensed projects:Engaged in pharmaceutical hard capsules,tablet,Granules,Powder,pill(honey pill,honey pill,Concentrated pills,water pill),mixture,syrup,liquor,tea,lotion,ointment,cream(Hormone),plaster,liquid extract,Decoction,Gargle,oral solution,Chinese herbal extract,Production and sales of APIs(Operate according to the approved items and deadlines of the license);Healthy food,food,cosmetic,disinfectant,hygiene products(antibacterial agent),Medical device production,General cargo,pharmaceutical production,Drug retail,Drug Wholesale(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:cosmetic,disinfectant,hygiene products(antibacterial agent)Sales;Planting and Cultivation of Chinese Herbal Medicines,Sales;drug research,Research and development of Chinese herbal medicine,Medical technology research and development,Promotion and Transfer;Transfer of new drug technology achievements,technical consulting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Fu Wai Hospital, founded in 1956.